Terms: = Head and neck cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Prognosis
37 results:
1. THBS1 promotes angiogenesis and accelerates ESCC malignant progression by the HIF-1/VEGF signaling pathway.
Zhou X; Xia Q; Chen M; Zhang X; Huang M; Zheng X; Wang S; Wu B; Du Z
Cell Biol Int; 2024 Mar; 48(3):311-324. PubMed ID: 38233982
[TBL] [Abstract] [Full Text] [Related]
2. Abnormal p16 expression and prognostic significance in esophageal squamous cell carcinoma.
Jiang D; Zhang X; Chen W; Peng R; Zhang X; Gao F; Huang Y; Gu W; Hou Y
Histol Histopathol; 2024 Feb; 39(2):201-209. PubMed ID: 37132443
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma.
Erul E; Guven DC; Ozbay Y; Altunbulak AY; Kahvecioglu A; Ercan F; Yesil MF; Ucdal MT; Cengiz M; Yazici G; Kuscu O; Suslu N; Gullu I; Onur MR; Aksoy S
Biomark Med; 2023 Jan; 17(2):87-99. PubMed ID: 37042459
[TBL] [Abstract] [Full Text] [Related]
4. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
[TBL] [Abstract] [Full Text] [Related]
5. Parathyroid carcinoma: Report of 10 patients and literature review.
Miao XY; Wang XL; Lyu ZH; Ba JM; Pei Y; Dou JT; Gu WJ; Du J; Guo QH; Chen K; Mu YM
Neuro Endocrinol Lett; 2022 Nov; 43(4):233-238. PubMed ID: 36528886
[TBL] [Abstract] [Full Text] [Related]
6. HIF-1α and Caspase-3 expression in aggressive papillary thyroid carcinoma.
Zhang L; Shi B; Hu M; Qian L
World J Surg Oncol; 2022 Nov; 20(1):353. PubMed ID: 36329448
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Significance of the Nodal Ratio and Number of Positive Nodes in Patients With Squamous Cell Carcinomas of the head and neck.
Reuter I; Müller HH; Wiegand S
Anticancer Res; 2022 Nov; 42(11):5567-5570. PubMed ID: 36288860
[TBL] [Abstract] [Full Text] [Related]
8. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study.
Ríos A; Rodríguez MA; Puñal JA; Moreno P; Mercader E; Ferrero E; Ruiz-Pardo J; Morlán MA; Martín J; Durán-Poveda M; Bravo JM; Casanova D; Egea MPS; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
Langenbecks Arch Surg; 2022 Dec; 407(8):3631-3642. PubMed ID: 36251077
[TBL] [Abstract] [Full Text] [Related]
9. Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysis.
Monteiro L; Mariano LC; Warnakulasuriya S
Oral Dis; 2024 Mar; 30(2):207-215. PubMed ID: 36103586
[TBL] [Abstract] [Full Text] [Related]
10. N
Chen B; Jiang W; Huang Y; Zhang J; Yu P; Wu L; Peng H
Oncogene; 2022 Apr; 41(15):2239-2253. PubMed ID: 35217794
[TBL] [Abstract] [Full Text] [Related]
11. Association of systemic inflammation and body mass index with survival in patients with resectable gastric or gastroesophageal junction adenocarcinomas.
Gao X; Pan Y; Han W; Hu C; Wang C; Chen L; Guo Y; Shi Y; Pan Y; Xie H; Yao L; Yang J; Zheng J; Li X; Liu X; Hong L; Li J; Li M; Ji G; Li Z; Xia J; Zhao Q; Fan D; Wu K; Nie Y
Cancer Biol Med; 2021 Feb; 18(1):283-297. PubMed ID: 33628601
[TBL] [Abstract] [Full Text] [Related]
12. Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of tango.
Sasahira T; Kurihara-Shimomura M; Shimomura H; Bosserhoff AK; Kirita T
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1659-1672. PubMed ID: 33620575
[TBL] [Abstract] [Full Text] [Related]
13. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic significance of C-MYC dysregulation in esophageal squamous cell carcinoma: a meta-analysis.
Shi X; Zhou R; Zheng L; Jiang M
Biomark Med; 2020 May; 14(7):599-609. PubMed ID: 32462905
[No Abstract] [Full Text] [Related]
15. Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.
Xu S; Sun B; Zhou R; Shi C; Han Y; Li J; Sun J; Tian Z; Zhang Z; Li J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):236-245.e2. PubMed ID: 31987673
[TBL] [Abstract] [Full Text] [Related]
16. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract] [Full Text] [Related]
17. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract] [Full Text] [Related]
18. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
[TBL] [Abstract] [Full Text] [Related]
19. [A comparative study of the short-term efficacy and long-term efficacy of systematic lymph node dissection and elective lymph node dissection in patients with early esophageal cancer].
Wu HR; Liu CQ; Guo MF; Mei XY; Tian JY; Xu MQ
Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):706-711. PubMed ID: 30157578
[No Abstract] [Full Text] [Related]
20. The Impact of Pathological Tumor Regression and Nodal Status on Survival and Systemic Disease in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Miyata H; Tanaka K; Makino T; Yamasaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Morii E; Mori M; Doki Y
Ann Surg Oncol; 2018 Aug; 25(8):2409-2417. PubMed ID: 29748887
[TBL] [Abstract] [Full Text] [Related]
[Next]
